Craig Stark, Ph.D., a professor at the University of California, Irvine, and a Dana Alliance member, urges caution about how neuroscience advances may influence the courts in the October Report on Progress. In the report, Dr. Stark discusses the neuroimaging of brain scans and the limitation of memory:
Last week, long-time Dana Alliance member Pasko Rakic, M.D., Ph.D., was honored as the 2014 Child Mind Institute Distinguished Scientist at the organization’s annual On the Shoulders of Giants symposium. Held at Hunter University’s Roosevelt House (Franklin and Eleanor Roosevelt called it home for many years), the symposium gave us the opportunity to hear from Rakic, as well as from one of his protégée’s, Nenad Sestan, M.D., Ph.D., and his colleague Matthew State, M.D., Ph.D.
Rakic began his scientific career in Belgrade, where he studied neurosurgery with plans to be a clinician. During his training he became fascinated with brain mapping and how different areas of the brain affected different body functions. This fascination lured him into research—and additional years of school—as he went for and completed his doctorate.
Dana Alliance member Barry Gordon, M.D., is familiar with autism on both a personal and professional level. Gordon, a behavioral neurologist and cognitive neuroscientist at Johns Hopkins with interests in disorders of speech, language, and memory, is also father to a severely autistic 22-year old son who cannot speak.
“It was beyond irony when our son proved to be unable to speak and unable to learn,” he said at a July Capitol Hill briefing, hosted by AAAS through the support of the Dana Foundation in conjunction with Rep. Chaka Fattah (D-Pa.). [See also our interview with him in 2012.]
Credit: Kavli Institute for Systems Neuroscience
British-American researcher John O’Keefe and Norwegian researchers May-Britt Moser and Edvard I. Moser were awarded this year’s Nobel Prize in Physiology or Medicine for discovering “an inner GPS, in the brain,” that makes navigation possible for virtually all creatures. The Mosers, members of the European Dana Alliance for the Brain, wrote on their research for Cerebrum in March: “Mapping Your Every Move.” Here’s Cerebrum editor Bill Glovin’s post on the essay from then:
Earlier this week, a study published in the journal Neurology reported that Alzheimer’s disease may be killing more than 500,000 people in the U.S. each year, making it possibly the third leading killer behind heart disease and cancer. As Brain Awareness Week (March 10-16) approaches, it’s as good a time as any to take stock of whether neuroscience is getting closer to finding a treatment for Alzheimer’s disease.
While the Obama administration’s $100 million Brain Initiative and the European Union’s $1 billion Human Brain Project give us reasons to hope for the future, the research outlined in “Mapping Your Every Move,” Cerebrum’s March feature, provides reason for optimism right now. Authors Edvard Moser, Ph.D., and May-Britt Moser, Ph.D. of the Kavli Institute in Norway are among a determined group of researchers worldwide who are making slow but steady progress in research that could lead to Alzheimer’s treatment.